COVID-19 experimental vaccine records huge success in first trial

COVID-19 experimental vaccine records huge success in first trial

- A COVID-19 experimental vaccine developed by Moderna Inc has proved safe and provoked immune responses all patients tested

- In the test was conducted on Tuesday, July 14, volunteers were given two doses of the vaccine

- The team which carried out the trials reported that patients showed high levels of virus-killing antibodies

PAY ATTENTION: Click “See First” under the “Following” tab to see Legit.ng News on your Facebook News Feed!

Scientists are inching closer to developing a vaccine for the coronavirus following a report which stated that a COVID-19 experimental vaccine developed by Moderna Inc was safe and provoked immune responses all patients tested in an initial safety trial.

Reuters reported that in the test conducted on Tuesday, July 14, patients who volunteered were given two doses of the vaccine.

COVID-19 experimental vaccine records huge success in first trial
Scientists seem to be inching closer to developing a vaccine for COVID-19. Photo credits: Forbes
Source: UGC

The team which carried out the trials reported that patients showed high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19.

Read also

Coronavirus: Traders reveal hike in cost of food items as Easter beckons

According to findings from the experiment which were also published in the New England Journal of Medicine, more than half of the volunteers experienced mild or moderate side effects like fatigue, headache, chills, muscle aches, or pain at the injection site.

Bloomberg citing the report stated that three of 14 patients given the highest dose experienced severe side effects, but said that dose is not being used in larger trials.

It was also disclosed that these reactions were likely to occur after the second dose and in people who got the highest dose.

Meanwhile, the leadership of the Lagos state House of Assembly has directed all its members to go for the COVID-19 test.

Adewale Adedeji, the lawmaker representing Ifako Ijaiye 1 constituency, made this known in a statement, adding that his own test result turned out negative, The Nation reports.

Adedeji indicated in the statement that the assembly's directive was issued on Sunday, July 12.

Read also

Coronavirus: Engaging activities you can do to avoid boredom following the stay at home order

“As directed by the leadership of the Lagos State House of Assembly, On Sunday, 12th of July, 2020; I went and submitted myself for the COVID-19 test, and I have gotten my result. The test result came out NEGATIVE," the lawmaker said.

Adedeji urged every resident of the state to take responsibility and observe all recommended preventive measures.

“Wash your hands for 30 seconds regularly, avoid social gatherings, maintain social distancing and at all times wear a face mask, the use of hand sanitizer should become a habit and finally, avoid touching your face and nose," the lawmaker advised.

In another report, the federal government has said that in order to address the testing deficit in Nigeria, it plans to establish one sample collection centre in every local government area in the country.

Already, a sample collection centre has been set up in the Federal Capital Territory (FCT), Abuja and that all government hospitals in the FCT have been designated as sample collection centres.

Read also

Coronavirus: Everything you need to know about the menacing pathogen

The Secretary to the Government of the Federation (SGF) and chairman, Presidential Task Force (PTF) on COVID-19, Mr Boss Mustapha, made this known on Monday, July 13.

He reiterated that contacting COVID-19 is not a death sentence, but not presenting oneself for testing or treatment when symptoms become observable could likely lead to avoidable death.

PAY ATTENTION: Download our mobile app to enjoy the latest news update

Coronavirus: Are Nigerians really afraid of COVID-19? New survey reveals more | Legit TV

Source: Legit.ng

Tags:
Online view pixel